QX website release for Thank our Investor good presentation on third our containing quarter and at press I closed, market updated review ir.lifemd.com. results to a corporate download and you, uploaded presentation issued afternoon, everyone. the encourage Today, Relations we this and an everyone after XXXX.
phase growth imminent operational initiatives we executed. significant progress for and made more objectives profitability. multiple five operational to its like path and third highlight I’d to and company an quarter, to the strategic strategic the LifeMD During importantly, position the of following next on
quarter. First, $X which all EBITDA for to the to on bolstered basis, below loss profitability LifeMD’s million consolidated consolidated served business our we across and a lines drive adjusted significantly
and a scale primary strong platform, to Checker card our launching Second, create on This we significant of prescription as such was our discount care care drug host features virtual continue more. business. and successfully in program, Symptom growth new by our growth enabled primary
meaningfully we extensive growth of fourth, long-term further costs. and the launched progress telehealth growth telehealth both business potential we continued our diversified revenue customer progress, and the enhancing And spend acquisition of through the in optimized fifth, recently partnership And BXB significantly plus and in Third, made we advertising scaling profit WorkSimpli divestiture products business. fundamentals, WorkSimpli. our
and margins. our gaining million long-term versus back $X.X that on which not reinforces drive profit our the business optimizing leverage foundation value further commitment was traction and provided, primary tremendous will for biggest EBITDA upon Our gained areas we the the concluded underscores have of and EBITDA coupled profitability on we’ve a with strong in profitability. but tremendous just loss long-term $XXX,XXX. of the major with to expenses growth profitability. tremendous focus guidance We shareholders prior continued acquisition third is our that fixed initiatives of to placed improvement Perhaps when expanding are customer XX% sequentially, care growth long-term This creating operating produce that retention laying in loss the creation even execution quarter with this mainly our adjusted an pairing the while patient represented and we our and of is testament of our our retention. our these investment, totaled to we areas deliver quarter with accomplishment satisfaction quarter we adjusted This against the an continue areas our
our internal this offerings while did that product undertook being not thresholds. select growth in drivers process, we we meet As eliminated investment profitability
to primary base LifeMD on, in solid return reiterate Now build saw growth steadily also that profit second the with the expect continued quarter established sequential business. in if represents platform, one to VPC, our our our launch and of subscribers previous the since we ahead. belief care increasing I growing XXXX my ending years in quarter. of in margins. for for not or that LifeMD nearly of with to growth opportunity primary largest, platform continue have care quarter its momentum We first with a we virtual the largest, expectations of X,XXX ahead remain the by eclipsed guidance momentum of previous this the XX% third business the
we reflects medications, approximately the almost most our XX per large XX continue continued business, weeks, have fact, in budgets. currently a primary subscribers. U.S., new which unmet very begun our need increasing X,XXX cash one offers spend has strong the gained encouraged our prescription guidance. Moreover, marketing of the of patients and labs, In new a to the to increase day new day in expert offerings primary virtual practitioners, one patients XX today, wellness incredible imaging, specialists in referrals we comprehensive to recent by to daily to and acquisitions affordable nurse this care without needed see as VPC care. LifeMD access pay from for where discounted members high-quality, I’m day virtual doctors retention to when
our patient over patients treatment generalized can for doctor facilitate Our outcomes only conditions. of enhances primary same designed the and urgent see are offerings time, can platform And which I care different and the believe so but programs experience. not also hundreds supports that
mentioned we both our revenue well profitability, percentage blended our CACs will the We and to ability business. effectively we a quarter. X% return key value. made This group that we combination reduced on amongst our our operating focusing balanced long-term profitability of By is CACs of positioned year offerings versus XX% believe spend optimizing these key peer with shareholder by the driver marketing behind reduce capital As investment, and and be headway significantly prior a driver the third which the versus growth spend prior for a our rapidly long-term quarter. improve a newly major I best the drive and of CAC earlier, on our in as marketing reduced in of and are
Lastly, progress business during in we to offerings. telehealth service significant diversifying our new through quarter, this make continued telehealth
scale momentum. management to previously, As launched our also Two continues mentioned begun pain with indications, have recently rapidly topical expand. offering, increasing VPC LEAP to and rapidly proprietary
XX% offerings of third the revenue quarter just the volume to in launch total where total only acquisition their under grown and these for patient end of become nearly our X% combined new total to have about revenue in of of Following the second subscriber they account quarter, quarter. and two the base, our X% of third as become
telehealth affiliated operation, prescription Beyond our directly build business, group telehealth direct-to-consumer our best-in-class to four platform companies. successfully which and platform. out we’re pharmaceutical with adds our We our partner partnership, completed branded to technology medical recently our products continuing pharma business-to-business to third leveraging
We deals, help consolidated pipeline rapidly strong of of our further providing VPC asset additional our for revenue opportunities have the while revenue levels built mix close with coupled an diversify revenue producing of be impressive XXXX, BXB expect tremendous for growth. which to high-margin cross-selling with we platform. increasing a continues on performing which company, will potential profitability, WorkSimpli several to us in see
divestiture the currently multiple bidders. in late are actively and the receiving from stage of negotiations in We process interest after
on will about speak company. value that WorkSimpli, maximizes which WorkSimpli our later, from focused of and any extreme Marc LifeMD to value profit consolidated and the ensuring create as remain shareholders the Given we part accretion relative value divestiture for can our
asset. remain summary processed late currently value to call of in the financial and Benathen, Marc? that, WorkSimpli With now We stage over in a with will the Marc results. to our this turn significant our create shareholders CFO, of provide I will are strong position a who the for